Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 226 (RNA5SP226) is a non-protein-coding, non-functional genomic sequence classified as a pseudogene of 5S ribosomal RNA. Pseudogenes arise by gene duplication or retrotransposition followed by mutation or loss of regulatory sequences, rendering them non-functional. They do not encode proteins or functional RNAs, nor do they participate in canonical biological activities. RNA5SP226 does not have known physiological, pathological, or pharmacological roles and is not relevant as a therapeutic target or biomarker. Its presence in genomic annotation reflects evolutionary history and genomic redundancy, rather than functional activity or disease association. Summary of correctness: This entry represents a miscategorization: ribosomal RNA pseudogenes are not valid molecular targets for pharmacology, disease association, or biomarker development. There is no evidence they fulfill any criteria relevant to drug targeting or functional genomics. If further specificity or correction is required, this entry should be removed or excluded from molecular target lists.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 226 (RNA5SP226).